jueves, 11 de marzo de 2021

Nitrosamines as Impurities in Drugs; Health Risk Assessment and Mitigation Public Workshop - 03/29/2021 - 03/30/2021 | FDA

Nitrosamines as Impurities in Drugs; Health Risk Assessment and Mitigation Public Workshop - 03/29/2021 - 03/30/2021 | FDA

No hay comentarios: